SK Biopharmaceuticals signs epilepsy drug licensing deal with Biohaven

J.B. Hunt stock plunges 10% after company warns third-quarter earnings will fall

Shares of J.B. Hunt plunged more than 10% Wednesday after the company warned of an earnings drop between 5% and 10%.

CNBC Stocks

Why is CoreWeave stock climbing today?

Investing.com

Sling Therapeutics raises $123m for thyroid eye disease drug trial

Investing.com